BMEA Biomea Fusion Inc

USD 15.07 2.32 18.196078
Icon

Biomea Fusion Inc (BMEA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 15.07

+2.32 (+18.20)%

USD 0.37B

3.33M

USD 46.00(+205.24%)

USD 34.00 (+125.61%)

Icon

BMEA

Biomea Fusion Inc (USD)
COMMON STOCK | NSD
USD 15.07
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 0.37B

USD 34.00 (+125.61%)

USD 15.07

Biomea Fusion Inc (BMEA) Stock Forecast

Show ratings and price targets of :
USD 46.00
(+205.24%)

Based on the Biomea Fusion Inc stock forecast from 8 analysts, the average analyst target price for Biomea Fusion Inc is USD 46.00 over the next 12 months. Biomea Fusion Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Biomea Fusion Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Biomea Fusion Inc’s stock price was USD 15.07. Biomea Fusion Inc’s stock price has changed by +50.25% over the past week, +36.26% over the past month and +109.60% over the last year.

No recent analyst target price found for Biomea Fusion Inc
No recent average analyst rating found for Biomea Fusion Inc

Company Overview Biomea Fusion Inc

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, pot...Read More

https://biomeafusion.com

900 Middlefield Road, Redwood City, CA, United States, 94063

103

December

USD

USA

Adjusted Closing Price for Biomea Fusion Inc (BMEA)

Loading...

Unadjusted Closing Price for Biomea Fusion Inc (BMEA)

Loading...

Share Trading Volume for Biomea Fusion Inc Shares

Loading...

Compare Performance of Biomea Fusion Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BMEA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biomea Fusion Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +3.81 (+1.09%) USD90.24B 26.31 16.84

ETFs Containing BMEA

Symbol Name BMEA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biomea Fusion Inc (BMEA) Stock

Based on ratings from 8 analysts Biomea Fusion Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 7 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on BMEA's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for BMEA is USD 46.00 over the next 12 months. The maximum analyst target price is USD 60 while the minimum anlayst target price is USD 28.

Unfortunately we do not have enough data on BMEA's stock to indicate if its overvalued.

The last closing price of BMEA's stock was USD 15.07.

The most recent market capitalization for BMEA is USD 0.37B.

Based on targets from 8 analysts, the average taret price for BMEA is projected at USD 46.00 over the next 12 months. This means that BMEA's stock price may go up by +205.24% over the next 12 months.

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $etfs_link

Filename: stock-details/faqs.php

Line Number: 256

Backtrace:

File: /var/www/html/stocktarget/application/views/stock-details/faqs.php
Line: 256
Function: _error_handler

File: /var/www/html/stocktarget/application/views/stock-details/stock-detailss.php
Line: 2400
Function: include

File: /var/www/html/stocktarget/application/controllers/Stock_details.php
Line: 839
Function: view

File: /var/www/html/stocktarget/index.php
Line: 322
Function: require_once

We can't find any ETFs which contains Biomea Fusion Inc's stock.

As per our most recent records Biomea Fusion Inc has 103 Employees.

Biomea Fusion Inc's registered address is 900 Middlefield Road, Redwood City, CA, United States, 94063. You can get more information about it from Biomea Fusion Inc's website at https://biomeafusion.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...